| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000003629 |
| Receipt No. | R000004401 |
| Official scientific title of the study | Phase II study of surgical resection following neoadjuvant chemoradiation using Gemcitibine and TS-1 in patients with potentially and borderline resectable pancreatic cancer |
| Date of disclosure of the study information | 2010/06/01 |
| Last modified on | 2018/11/23 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Phase II study of surgical resection following neoadjuvant chemoradiation using Gemcitibine and TS-1 in patients with potentially and borderline resectable pancreatic cancer | |
| Title of the study (Brief title) | Phase II study of surgical resection following neoadjuvant chemoradiation in pancreatic cancer | |
| Region |
|
|
| Condition | ||
| Condition | potentially and borderline resectable pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | to examine the efficacy and safety |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | frequency of radical resection (R0) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | To investigate the frequency of histological curative resection following chemoradiation using Gemcitabine and TS-1in patients with potentially resectable pancreatic cancer | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with Histo-cytologically confirmed pancreatic cancer
2.Patients who have not undergone chemo and/or radiotherapy 3.Patients with radiologically defined patentially resectable pancreatic cancer 4.Patients with no metastatic disease confirmed by staging laparoscopy 5.Patients with Performance status of 0/1 6.Patients with sustained organ function 7.Patients with potentially resectable pancreatic cancer by CT following neoadjuvant chemoradiation 8.Patients who received informed consent |
|||
| Key exclusion criteria | 1) Patients with other active cancers
2) Patients with watery diarrhea 3) Intractable pleural and pericardical effusion, or ascites 4) Severe co-morbid diseases 5) Pregnancy or insufficient contraception 6) Past history of severe drug-allergy 7) Active bacterial or viral infection 8) younger than 20 years old or older than 90 years old. 9) No written informed consent of the patients 10) Pregnancy or insufficient contraception 11) HIV infection 12) Doubtful understanding or contractual capacity of the patient 13) Patients seems inadequate for this study by investigator(s) |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Sohei SATOI MD |
| Organization | Kansai Medical University Hospital |
| Division name | Department of Surgery |
| Address | 2-3-1, Shin-machi, Hirakata, Osaka 573-1191 |
| TEL | 072-804-0101 |
| Public contact | |
| Name of contact person | Sohei SATOI MD |
| Organization | Kansai Medical University Hospita |
| Division name | Department of Surgery |
| Address | |
| TEL | |
| Homepage URL | |
| satoi@hirakata.kmu.ac.jp | |
| Sponsor | |
| Institute | Kansai Medical University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004401 |